Belite Bio
BLTE
Belite Bio (BLTE) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Maintained | Overweight | $270.00 from $266.00 | Aug 14, 2026 |
| Morgan Stanley | Maintained | Overweight | $206.00 from $201.00 | Aug 14, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $214.00 from $200.00 | Aug 12, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $200.00 | Jun 15, 2026 |
| Mizuho | Maintained | Outperform | $215.00 from $223.00 | May 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $200.00 | May 21, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $200.00 | Apr 22, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $200.00 | Apr 13, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $266.00 from $200.00 | Mar 3, 2026 |
| Morgan Stanley | Maintained | Overweight | $201.00 from $191.00 | Mar 3, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $200.00 from $185.00 | Mar 3, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $185.00 | Jan 28, 2026 |
| B of A Securities | Initiated Coverage | Buy | $195.00 | Jan 26, 2026 |
| Morgan Stanley | Initiated Coverage | Overweight | $191.00 | Jan 6, 2026 |
| Mizuho | Upgraded | Neutral → Outperform | $194.00 from $105.00 | Dec 2, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $185.00 from $98.00 | Dec 1, 2025 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | $154.00 | Nov 24, 2025 |
| Mizuho | Initiated Coverage | Neutral | $105.00 | Nov 20, 2025 |
| Benchmark | Maintained | Buy | $132.00 from $80.00 | Oct 31, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $98.00 from $100.00 | Sep 15, 2025 |
Frequently asked questions
What is the latest analyst rating on BLTE?
On Aug 14, 2026, Cantor Fitzgerald maintained Belite Bio at Overweight with a price target of $270.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.